In the context of estrogen receptor-positive (ER+) BC, miR-204 can bind to the 3′-UTR of the gene COX5A, inhibiting its expression, leading to reduced viability and invasiveness of BC cells, and sensitizing them to chemotherapy drugs like Doxorubicin (DOX). Here, ESR1 is linked to breast cancer.